Capvizr
News · All summaries
Healthcare & Life Sciences
Luminai
Series B$38 million
RoundSeries B
Amount$38 million
LeadPeak XV
DateApril 10, 2026
THE DEAL, AT A GLANCE

Luminai

From the announcement
Who is involvedBacked by Peak XVFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedLuminai raised $38M Series B, announced 2026-04-10From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersLuminai’s $38M Series B positions the company as a mid-sized Healthcare & Life Sciences financing in an active funding tape, with the round below the sector median but…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Luminai · Financing Record

Explore source-linked visual explanations for Luminai. Unsupported claims are withheld while source review continues.

Record 2550 · Recorded date: 2026-04-10

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime